Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 2/2010

01-04-2010 | Review

Renal dysfunction in chronic liver disease

Authors: Andy Slack, Andrew Yeoman, Julia Wendon

Published in: Critical Care | Issue 2/2010

Login to get access

Abstract

This article is one of ten reviews selected from the Yearbook of Intensive Care and Emergency Medicine 2010 (Springer Verlag) and co-published as a series in Critical Care. Other articles in the series can be found online at http://​ccforum.​com/​series/​yearbook. Further information about the Yearbook of Intensive Care and Emergency Medicine is available from http://​www.​springer.​com/​series/​2855.
Literature
1.
Perz JF, Armstrong GL, Farrington LA, Hutin YJF, Bell BP: The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006, 45: 529-538. 10.1016/j.jhep.2006.05.013.CrossRefPubMed
2.
Neuschwander-Tetri BA, Caldwell SH: Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003, 37: 1202-1219. 10.1053/jhep.2003.50193.CrossRefPubMed
3.
4.
Marrero JA, Fontana RJ, Su GL, Conjeevaram HS, Emick DM, Lok AS: NAFLD may be a common underlying liver disease in patients with hepatocellular carcinoma in the United States. Hepatology. 2002, 36: 1349-1354.CrossRefPubMed
5.
Bash LD, Astor BC, Coresh J: Risk of incident ESRD: A comprehensive look at cardiovascular risk factors and 17 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2010
6.
Luyckx VA, Brenner BM: Low birth weight, nephron number, and kidney disease. Kidney Int. 2005, S68-77. 10.1111/j.1523-1755.2005.09712.x. Suppl Aug
7.
Sabry AA, Sobh MA, Irving WL, et al: A comprehensive study of the association between hepatitis C virus and glomerulopathy. Nephrol Dial Transpl. 2002, 17: 239-245. 10.1093/ndt/17.2.239.CrossRef
8.
9.
Appel G: Viral infections and the kidney: HIV, hepatitis B, and hepatitis C. Cleve Clin J Med. 2007, 74: 353-360. 10.3949/ccjm.74.5.353.CrossRefPubMed
10.
Ohba S, Kimura K, Mise N, et al: Differential localization of s and e antigens in hepatitis B virus-associated glomerulonephritis. Clin Nephrol. 1997, 48: 44-47.PubMed
11.
Russell RT, Pinson CW: Surgical management of polycystic liver disease. World J Gastro. 2007, 13: 5052-5059.CrossRef
12.
Snanoudj R, Durrbach A, Gauthier E, et al: Changes in renal function in patients with familial amyloid polyneuropathy treated with orthotopic liver transplantation. Nephrol Dial Transpl. 2004, 19: 1779-1785. 10.1093/ndt/gfh063.CrossRef
13.
Swan SK: The search continues-an ideal marker of GFR. Clin Chem. 1997, 43: 913-914.PubMed
14.
Tomlanovich S, Golbetz H, Perlroth M, Stinson E, Myers BD: Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy. Am J Kidney Dis. 1986, 8: 332-337.CrossRefPubMed
15.
Takabatake T, Ohta H, Ishida Y, Hara H, Ushiogi Y, Hattori N: Low serum creatinine levels in severe hepatic disease. Arch Intern Med. 1988, 148: 1313-1315. 10.1001/archinte.148.6.1313.CrossRefPubMed
16.
Slack AJ, Wendon J: The liver and kidney in critically ill patients. Blood Purif. 2009, 28: 124-134. 10.1159/000227281.CrossRefPubMed
17.
Epstein M: Hepatorenal syndrome. Therapy in Nephrology and Hypertension - A companion to Brenner and Rector's The Kidney. Edited by: Brady HR, Wilcox CS. 1999, WB Saunders, Mayland Heights, 45-50.
18.
Cholongitas E, Shusang V, Marelli L, et al: Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther. 2007, 26: 969-978.CrossRefPubMed
19.
Mehta RL, Kellum JA, Shah SV, et al: Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007, 11: R31-10.1186/cc5713.PubMedCentralCrossRefPubMed
20.
Kellum JA: Defining and classifying AKI: one set of criteria. Nephrol Dial Transpl. 2008, 23: 1471-1472. 10.1093/ndt/gfn012.CrossRef
21.
22.
Senousy BE, Draganov PV: Evaluation and management of patients with refractory ascites. World J Gastro. 2009, 15: 67-80. 10.3748/wjg.15.67.CrossRef
23.
Abuelo J: Normotensive ischemic acute renal failure. N Engl J Med. 2007, 357: 797-805. 10.1056/NEJMra064398.CrossRefPubMed
24.
Mandall MS, Lindenfield J, Tsou M-Y, Zimmerman M: Cardiac evaluation of liver transplant candidates. World J Gastro. 2008, 12: 3445-3451. 10.3748/wjg.14.3445.CrossRef
25.
Betrosian AP, Agarwal B, Douzinas EE: Acute renal dysfunction in liver diseases. World J Gastro. 2007, 13: 5552-5559.CrossRef
26.
Gines P, Martin P-Y, Niederberger M: Prognostic significance of renal dysfunction in cirrhosis. Kidney Int. 1997, 51 (Suppl): S77-S82.
27.
Garcia-Tsao G, Parikh CR, Viola A: Acute Kidney Injury in cirrhosis. Hepatology. 2008, 48: 2064-2077. 10.1002/hep.22605.CrossRefPubMed
28.
Sheer TA, Runyon BA: Spontaneous bacterial peritonitis. Dig Dis. 2005, 23: 39-46. 10.1159/000084724.CrossRefPubMed
29.
Sanyal A, Boyer T, Garcia-Tsao G, et al: A randomized, prospective, double blind placebo-controlled trial of terlipressin for type I hepatorenal syndrome. Gastroenterology. 2008, 134: 1360-1368. 10.1053/j.gastro.2008.02.014.PubMedCentralCrossRefPubMed
30.
Martin-Lahi M, Pepin M, Guevara M, et al: Terlipressin and albumin vs albumin in patients with cirrhosis and heptorenal syndrome: a randomized study. Gastroenterology. 2008, 134: 1352-1359. 10.1053/j.gastro.2008.02.024.CrossRef
31.
Coca SG, Yalavarthy R, Concato J, Parikh CR: Biomarkers for the diagnosis and risk stratification of acute kidney injury: A systematic review. Kidney Int. 2008, 73: 1008-1016. 10.1038/sj.ki.5002729.CrossRefPubMed
32.
Mishra J, Dent C, Tarabishi R, et al: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005, 365: 1231-1238. 10.1016/S0140-6736(05)74811-X.CrossRefPubMed
33.
Herget-Rosenthal S, Marggraf G, Husing J, et al: Early detection of acute renal failure by serum cystatin C. Kidney Int. 2004, 66: 1115-1122. 10.1111/j.1523-1755.2004.00861.x.CrossRefPubMed
34.
Parikh CR, Abraham E, Ancukiewicz M, Edelstein CL: Urine IL-18 is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol. 2005, 16: 3046-3052. 10.1681/ASN.2005030236.CrossRefPubMed
35.
36.
Uchino S, Kellum JA, Bellomo R, et al: Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA. 2005, 294: 813-818. 10.1001/jama.294.7.813.CrossRefPubMed
37.
Niemann CU, Walia A, Waldman J, et al: Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin. Liver Transpl. 2009, 15: 1852-1860. 10.1002/lt.21938.CrossRefPubMed
38.
Kidney Disease Outcomes Quality Initiative: Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002, 39: S1-S266. 10.1016/S0272-6386(02)70081-4.
39.
Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16: 31-41. 10.1159/000180580.CrossRefPubMed
40.
Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004, 351: 1296-1305. 10.1056/NEJMoa041031.CrossRefPubMed
41.
Bauer C, Melamed ML, Hostetter TH: Staging of Chronic Kidney Disease: Time for a Course Correction. J Am Soc Nephrol. 2008, 19: 844-846. 10.1681/ASN.2008010110.CrossRefPubMed
42.
Levey AS, Greene T, Beck GJ, et al: Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of Diet in Renal Disease Study group. J Am Soc Nephrol. 1999, 10: 2426-2439.PubMed
43.
Winearls CG, Glassock RJ: Dissecting and refining the staging of chronic kidney disease. Kidney Int. 2009, 75: 1009-1014. 10.1038/ki.2009.49.CrossRefPubMed
44.
Poggio ED, Rule AD: A critical evaluation of chronic kidney disease-should isolated reduced estimated glomerular filtration rate be considered a 'disease'?. Nephrol Dial Transpl. 2008, 24: 698-700. 10.1093/ndt/gfn704.CrossRef
45.
Skulzacek PA, Szewc RG, Nolan CR, Riley DJ, Lee S, Pergola PE: Prediciton of GFR in liver transplant candidates. Am J Kidney Dis. 2003, 42: 1169-1176. 10.1053/j.ajkd.2003.08.017.CrossRef
46.
Proulx NL, Akbari A, Garg AX, Rostom A, Jaffey J, Clark HD: Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis. Nephrol Dial Trans. 2005, 20: 1617-1622. 10.1093/ndt/gfh839.CrossRef
47.
Woitas RP, Stoffel-Wagner B, Flommersfeld S, et al: Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem. 2000, 46: 712-715.PubMed
48.
Poge U, Gerhardt T, Stoffel-Wagner B, Klehr HU, Sauerbruch T, Woitas RP: Calculation of glomerular filtration rate based on cystatin C in cirrhotic patients. Nephrol Dial Transpl. 2006, 21: 660-664. 10.1093/ndt/gfi305.CrossRef
49.
Bolignano D, Coppolino G, Campo S, et al: Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with severity of renal disease in proteinuric patients. Nephrol Dial Transpl. 2008, 23: 414-416. 10.1093/ndt/gfm541.CrossRef
50.
Neuberger JM, Gimson A, Davies M, et al: Selection of patients for liver transplantation and allocation of donated livers in the UK. GUT. 2008, 57: 252-257. 10.1136/gut.2007.131730.CrossRefPubMed
51.
Bahirwani R, Reddy KR: Outcomes after liver transplantation: chronic kidney disease. Liver Transpl. 2009, 15 (Suppl 2): S70-S74.CrossRefPubMed
52.
Bahirwani R, Campbell MS, Siropaides T, et al: Transplantation: impact of pretransplant renal insufficiency. Liver Transpl. 2008, 14: 665-671. 10.1002/lt.21367.CrossRefPubMed
53.
Ojo AO, Held PJ, Port FK, et al: Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. 2003, 349: 931-940. 10.1056/NEJMoa021744.CrossRefPubMed
54.
Neuberger JM, Mamelokb RD, Neuhausc P, et al: Delayed Introduction of Reduced-Dose Tacrolimus, and Renal Function in Liver Transplantation: The 'ReSpECT' Study. Am J Transp. 2009, 9: 327-336. 10.1111/j.1600-6143.2008.02493.x.CrossRef
55.
EBPG Expert Group on Renal Transplantation: European Best Practice Guidelines for Renal Transplantation. Section I: Evaluation, selection and preparation of the potential transplant recipient. Nephrol Dial Transplant. 2000, 15 (Suppl 7): 3-38.CrossRef
Metadata
Title
Renal dysfunction in chronic liver disease
Authors
Andy Slack
Andrew Yeoman
Julia Wendon
Publication date
01-04-2010
Publisher
BioMed Central
Published in
Critical Care / Issue 2/2010
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc8855

Other articles of this Issue 2/2010

Critical Care 2/2010 Go to the issue

Review

Cerebral perfusion in sepsis

Commentary

Where does the lactate come from? A rare cause of reversible inhibition of mitochondrial respiration

Research

Nicotine withdrawal and agitation in ventilated critically ill patients

Letter

Non-invasive ventilation for critically ill patients with pandemic H1N1 2009 influenza A virus infection

Review

Clinical review: Practical recommendations on the management of perioperative heart failure in cardiac surgery

Commentary

Critical care in the developing world - a challenge for us all